ACTRN12616000258459
Completed
未知
A Pilot Trial evaluating the impact of mindfulness-enhanced internet-delivered cognitive behavioural therapy (MEiCBT) on symptoms of depression and anxiety
St Vincent's Hospital Sydney0 sites25 target enrollmentFebruary 24, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Major Depressive Disorder
- Sponsor
- St Vincent's Hospital Sydney
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Self\-identified as suffering from depression and/or anxiety.
- •\* Meet criteria for either Major Depressive Disprder (MDD), Generalized Anxiety Disorder (GAD), Social Phobia (SP), Panic Disorder (PD), Agoraphobia (AG), or Obsessive\-Compulsive Disorder (OCD) according to the Mini International Neuropsychiatric Interview Version 5\.0\.0 (MINI)
- •\* Australian resident status
- •\* At least 18 years of age
- •\* Access to a computer, printer, and the internet
- •\* If taking medication, must have been taking the same dose for at least 1 month and not intend to change that dose during the course of the program.
- •\* Prepared to provide name, phone number, and address, and to provide the name and phone number of a local general practitioner.
- •\* Willing to provide informed consent.
Exclusion Criteria
- •\- Does not meet diagnostic criteria for an anxiety or depressive disorder.
- •\- Currently experiencing severe depression symptoms (score of 23 or above on the PHQ\-9\).
- •\- Regularly using illicit drugs or regularly consuming more than three standard drinks per day
- •\- Current regular use of benzodiazepines
- •\- Current use of atypical anti\-psychotics
- •\- Currently experiencing a psychotic mental illness or bipolar disorder
- •\- Completed an online program for depresison and/or anxiety in the past year
- •\- Severe symptoms of suicidal ideation (defined as responding 3 to the PHQ\-9 question 9 item that assesses the frequency of suicidal ideation over the past fortnight).
- •\-Those scoring 1 or 2 on the Patient Health Questionnaire\_9 Item (PHQ\-9\) item 9 will require risk assessment with the responsible clinician before being admitted into the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Melatonin on sleep architecture in COPD patientsHealth Condition 1: null- Moderate and severe stable COPD.CTRI/2018/04/013444Artemis Hospital
Completed
Not Applicable
Efficacy of a one-week overcoming shyness programSocial Anxiety DisorderMental Health - AnxietyACTRN12620000135910niversity of New South Wales17
Completed
Phase 4
A study on the influence of obesity on the protection after influenza vaccination in children aged 9-17 years.Obesity in children and adolescentsResponse to influenza vaccinationInflammatory and Immune System - Normal development and function of the immune systemInflammatory and Immune System - Other inflammatory or immune system disordersDiet and Nutrition - ObesityACTRN12617001086358Women's and Children's Hospital44
Recruiting
Not Applicable
The effect of CUTICERIN® with or without a Regenerative Epithelial Suspension (RES™), on pigmentation of donor sites in children: The pilot randomised DRESSIng TrialACTRN12620000227998Department of Industry , Innovation and Science40
Completed
Phase 2
Study of a combination of fenugreek/phaseolamin as a new weight loss agentObesityDiet and Nutrition - ObesityACTRN12607000130460Southern European Health Marketing Ltd39